DM Clinical Research is celebrating its 20th anniversary, marking two decades of expanding access to clinical trials and helping accelerate the development of innovative therapies for patients across the United States. Founded in 2006 with a vision to make clinical research more accessible and patient-centered, the organization has grown into one of the nation’s leading integrated clinical research networks, now operating more than 35 research sites and providing access to a patient population of 1.97 million individuals across 32 therapeutic areas.
Over the past two decades, DM Clinical Research has enrolled more than 35,000 patients in clinical trials, contributing to the development of safe and life-changing therapies. The company partners with leading pharmaceutical, biotechnology, and healthcare organizations, as well as contract research organizations (CROs), to conduct high-quality trials while delivering strong enrollment performance and diverse patient access. Its integrated operating model combines local physician relationships with centralized infrastructure to ensure quality, speed, and consistent execution for sponsors and CRO partners.
“Reaching 20 years is incredibly meaningful to me. When I think about DM Clinical Research, I think first about the people, the employees who have poured their talent and heart into this organization, and the patients who have trusted us to be part of their healthcare journey,” said Mohammad Millwala, Founder and CEO of DM Clinical Research. “We’ve experienced so much growth and change over the past two decades, but what has never changed is our commitment to our patients and to doing meaningful work that makes a difference.”
The company’s commitment to excellence has been recognized through industry honors, including the SPRIA Award for vaccine enrollment, the Excellence in Patient Centricity Award, ViE’s Best Clinical Trial Network Award, and the SCRS Site Spark Award. In 2025, Millwala was also honored with the SCRS Christine K. Pierre Site Impact Award for his leadership in advancing clinical research.
As part of its mission to expand access to clinical research, DM Clinical Research continues to grow its presence in underserved communities, ensuring more patients have the opportunity to participate in trials. The company’s 20th anniversary theme, “Champions of Clinical Research: 20 Years of Impact,” reflects the teamwork and dedication that have fueled its growth. Guided by core values such as Think Forward, Find a Way, and Create Impact, DM Clinical remains focused on investing in its people and embracing new technologies.
“As we celebrate this milestone, we remain focused on what’s next,” added Millwala. “The next chapter for DM Clinical is about expanding access to research, embracing new technologies, and ensuring more patients have the opportunity to participate in clinical trials that can change lives.” Looking ahead, DM Clinical plans continued expansion into new communities, broader therapeutic expertise, and increased investment in innovative technologies to improve patient access to clinical research.
